lifestyle.thedishh.com

Author: Bridge to Life, Ltd.

Groundbreaking Global Study Establishes First International Benchmark Framework for Pediatric Liver Transplantation

May 11, 2026
Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment

May 11, 2026
Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

May 4, 2026
New Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation

May 4, 2026
Bridge to Life Announces First Commercial Use of VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System by Major U.S. Transplant Center Following FDA Clearance, Signaling Early Physician Confidence

April 30, 2026
Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Ever U.S. Approval for Cold Machine Perfusion in Liver Transplant Preservation

January 20, 2026
/DISREGARD RELEASE: Bridge to Life, Ltd./

January 20, 2026
Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers

January 20, 2026